#6100
Aspergillus
fumigatus IgG ELISA
ELISA kit for the diagnosis of human aspergillosis
Lot 2509A (Expiry date: 19.10.2026)
Production date : 20.02.2025
Results of quality control 4 (after
20 months), date: 21.10.2026
No serum blank (average) : 0.139
| Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
0.004 |
-0.002 |
0.000 |
-0.001 |
0.000 |
0 |
Negative control serum
(N° 6100-06) |
0.048 |
0.052 |
0.047 |
0.042 |
0.047 |
2 |
Weak positive serum
(N° 6100-07) |
0.499 |
0.492 |
0.483 |
0.456 |
0.482 |
23 |
Positive control
serum
(N° 6100-08) |
2.174 |
2.104 |
2.049 |
2.073 |
2.100 |
100 |
Validation criteria:
| |
Criterion |
Measure |
Valid |
| Absorbance of positive serum 6100-08 |
> 1.200 |
2.100 |
Yes |
| Absorbance of weak positive serum 6100-07, as % of positive serum
|
> 11 % |
23 % |
Yes |
| Absorbance of negative serum 6100-06, as % of positive serum |
< 8 % |
2 % |
Yes |
| Absorbance of no serum blank |
< 0.350 |
0.139 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|